Pin1 protein associates with neuronal lipofuscin: Potential consequences in age-related neurodegeneration

Experimental Neurology

Volumn 199, Issue 2, 2006, Pages 328-338

  Hashemzadeh Bonehi, Lida ^a   Phillips, Roger Guy ^b   Cairns, Nigel John ^c   Mosaheb, Sabrina ^b   Thorpe, Julian Robert ^b  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

^b School of Life Sciences   (United Kingdom)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Brain; Fluorescence microscopy; Immunogold labeling transmission electron microscopy; Lipofuscin; Pin1

Indexed keywords

CYCLOPHILIN; LIPOFUSCIN; PEPTIDYLPROLYL ISOMERASE PIN1; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; AGING; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; CORRELATION ANALYSIS; DEGENERATIVE DISEASE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; HUMAN; HUMAN TISSUE; NERVE DEGENERATION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

ADULT; AGE FACTORS; AGED, 80 AND OVER; AGING; CHILD, PRESCHOOL; DEMENTIA; DIAGNOSTIC IMAGING; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; INDOLES; LIPOFUSCIN; MICROSCOPY, ELECTRON, TRANSMISSION; NEURONS; PEPTIDYLPROLYL ISOMERASE; POSTMORTEM CHANGES; PROTEIN BINDING;

EID: 33745275797     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2005.12.030     Document Type: Article

References (42)

1. Ames B.N., Shigenaga M.K., and Hagen T.M. Oxidants, antioxidants and the degenerative diseases of aging. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 7915-7922
2. Bajaj N.P.S., Al-Sarraj S.T., Anderson V., Kibble M., Leigh N., and Miller C.C.J. Cyclin-dependent kinase-5 is associated with lipofuscin in motor neurons in amyotrophic lateral sclerosis. Neurosci. Lett. 245 (1998) 45-48
3. Beckman K.B., and Ames B.N. The free radical theory of aging matures. Physiol. Rev. 78 (1998) 547-581
4. Bendarski E., and Lynch G. Cytosolic proteolysis of t by cathepsin D in hippocampus following suppression of cathepsin B and L. J. Neurochem. 67 (1996) 1846-1855
5. Brunk U.T., and Terman A. Lipofuscin: mechanisms of age-related accumulation and influence on cell function. Free Radical Biol. Med. 33 (2002) 611-619
6. Cairns N.J., Grossman M., Arnold S.E., Burn D.J., Jaros E., Perry R.H., Duyckaerts C., Stankoff B., Pillon B., Skullerud K., Cruz-Sanchez F.F., Bigio E.H., Mackenzie I.R., Gearing M., Juncos J.L., Glass J.D., Yokoo H., Nakazato Y., Mosaheb S., Thorpe J.R., Uryu K., Lee V.M., and Trojanowski J.Q. Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease (NIFID). Neurology 63 (2004) 1376-1384
7. Ditaranto-Desimone K., Saito M., Tekirian T.L., Saito M., Berg M., Dubowchik G., Soreghan B., Thomas S., Marks N., and Yang A.J. Neuronal endosomal/lysosomal membrane destabilization activates caspases and induces abnormal accumulation of the lipid secondary messenger ceramide. Brain Res. Bull. 59 (2003) 523-531
8. Dowson J.H. Neuronal liposuscin accumulation in aging and Alzheimer's dementia: a pathogenetic mechanism?. Br. J. Psychiatry 140 (1982) 142-148
9. Drach L.M., Bohl J., and Geobel H.-H. The lipofuscin content of nerve cells of the inferior olivary nucleus in Alzheimer's disease. Dementia 5 (1994) 234-239
10. Galvan M., David J.P., Delacourte A., Luna J., and Mena R. Sequence of neurofibrillary changes in aging and Alzheimer's disease: a confocal study with phospho-tau antibody, AD2. J. Alzheimer's Dis. 3 (2001) 417-425
11. Gray D.A., and Woulfe J. Lipofuscin and aging: a matter of toxic waste. Sci. Aging Knowledge Environ. 5 (2005) re1 10.1126/sageke.2005.5.re1
12. Hamdane M., Smet C., Sambo A.V., Leroy A., Wieruszeski J.M., Delobel P., Maurage C.A., Ghestem A., Wintjens R., Begard S., Sergeant N., Delacourte A., Horvath D., Landrieu I., Lippens G., and Buee L. Pin1-A therapeutic target in Alzheimer neurodegeneration. J. Mol. Neurosci. 19 (2002) 275-287
13. Harman D. Lipofuscin and ceroid formation: the cellular recycling system. Adv. Exp. Med. Biol. 266 (1989) 3-15
14. Holzer M., Gartner U., Stobe A., Hartig W., Gruschka H., Bruckner M.K., and Arendt T. Inverse association of Pin1 and tau accumulation in Alzheimer's disease hippocampus. Acta Neuropathol. 104 (2002) 471-481
15. Ikeda K., Akiyama H., Araj T., Kondo H., Haga C., Iritani S., and Kuniaki T. Alz-50/Gallyas-positive lysosome-like intraneuronal granules in Alzheimer's disease and control brains. Neurosci. Lett. 258 (1998) 113-116
16. Itakura K., and Uchida K. Evidence that malondialdehyde-derived aminoenimine is not a fluorescent age pigment. Chem. Res. Toxicol. 14 (2001) 473-475
17. Itakura K., Oya-Ito T., Osawa T., Yamada S., Toyokuni S., Shibata N., Kobayashi M., and Uchida K. Detection of lipofuscin like fluorophore in oxidized human low-density lipoprotein, 4-hydroxy-2-nonenal as a potential source of fluorescent chromophore. FEBS Lett. 473 (2000) 249-253
18. Liou Y.-C., Sun A., Ryo A., Zhou X.Z., Yu Z.-X., Huang H.-K., Uchida T., Bronson R., Bing G., Li X., Hunter T., and Lu K.P. Role of the prolyl isomerase Pin1 in protecting against age-dependent neurodegeneration. Nature 424 (2003) 556-561
19. Lu K.P. Pinning down cell signalling, cancer and Alzheimer's disease. Trends Biochem. Sci. 29 (2004) 200-209
20. Lu K.P., Hanes S.D., and Hunter T. A human peptidyl-prolyl isomerase essential for regulation of mitosis. Nature 380 (1996) 544-547
21. Lu P.-J., Wulf G., Zhou X.Z., Davies P., and Lu K.P. The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein. Nature 399 (1999) 784-788
22. Lu K.P., Liou Y.C., and Zhou X.Z. Pinning down proline-directed phosphorylation signaling. Trends Cell Biol. 12 (2002) 164-172
23. Mann D.M.A., and Sinclair K.G.A. The quantitative assessment of lipofuscin pigment, cytoplasmic RNA and nucleolar volume in senile dementia. Neuropathol. Appl. Neurobiol. 4 (1978) 129-135
24. Mosaheb S., Thorpe J.R., Hashemzadeh-Bonehi L., Bigio E.H., Gearing M., and Cairns N.J. Neuronal intranuclear inclusions are ultrastructurally and immunologically distinct from cytoplasmic inclusions of neuronal intermediate filament inclusion disease (NIFID). Acta Neuropathol. 110 (2005) 360-368
25. Nakanishi H., Amano T., Sastradipura D.F., Yoshimine Y., Tsukuba T., Tanabe K., Hirostu I., Ohono T., and Yamamoto K. Increased expression of cathepsin E and D in neurons of the aged rat brain and their colocalization with lipofuscin and carboxy-terminal fragments of Alzheimer amyloid precursor protein. J. Neurochem. 68 (1997) 739-749
26. Nixon R.A., Cataldo A.M., and Mathews P.M. The endosomal-lysosomal system of neurons in Alzheimer's disease pathogenesis: a review. Neurochem. Res. 25 (2000) 1161-1172
27. Peters A., Palay S.L., and Webster H.deF. The Fine Structure of the Nervous System: Neurons and Their Supporting Cells. 3rd ed. (1991), Oxford Univ. Press
28. Porta E.A. Advances in age pigment research. Arch. Gerontol. Geriatr. 12 (1991) 303-320
29. Porta E.A. Pigments in aging: an overview. Ann. N. Y. Acad. Sci. 959 (2002) 57-65
30. Ramakrishnan P., Dickson D.W., and Davies P. Pin1 colocalization with phosphorylated tau in Alzheimer's disease and other tauopathies. Neurobiol. Dis. 14 (2003) 251-264
31. Romijn H.J., van Uum J.F.M., Emmering J., Goncharuk V., and Buijs R.M. Colocalization of VIP with AVP in neurons of the human paraventricular, supraoptic and suprachiasmatic nucleus. Brain Res. 832 (1999) 47-53
32. Sitte N., Huber M., Grune T., Ladhoff A., Doecke W.D., Von Zglinicki T., and Davies K.J. Proteosome inhibition by lipofuscin/ceroid during postmitotic aging of fibroblasts. FASEB J. 14 (2000) 1490-1498
33. Smet C., Sambo A.-V., Wieruszeski J.-M., Leroy A., and Landrieu I. The peptidyl prolyl cis/trans-isomerase Pin1 recognizes the Phospho-Thr212-Pro213 site on tau. Biochemistry-US 43 (2004) 2032-2040
34. Stojanovic A., Roher A.E., and Ball M.J. Quantitative analysis of lipofuscin and neurofibrillary tangles in the hippocampal neurons Alzheimer's disease brains. Dementia 5 (1994) 229-233
35. Sultana, R., Boyd-Kimball, D., Poon, H.F., Cai, J., Pierce, W.M., Klein, J.B., Markesbery, W.R., Zhou, X.Z., Lu, K.P., Butterfield, D.A., in press. Oxidative modification and down-regulation of Pin1 in Alzheimer's disease hippocampus: a redox proteomics analysis. Neurobiol. Aging.
36. Terman A., and Brunk U.T. Lipofuscin: mechanisms of formation and increase with age. AMPIS 106 (1998) 265-276
37. Terman A., and Sandberg S. Protease inhibition enhances lipofuscin formation. Ann. N. Y. Acad. Sci. 973 (2002) 309-312 (Part IV; Signal Transduction Stress Response, and Aging)
38. Thorpe J.R. The application of LR gold resin for immunogold labelling. In: Hajibagheri M.A. (Ed). Electron Microscopy Methods and Protocols. Methods Mol. Biol. Series vol. 117 (1999), Humana Press Inc., USA 99-110
39. Thorpe J.R., Rulten S.L., and Kay J.E. The binding of a putative and a known chaperone protein revealed by immunogold labelling transmission electron microscopy: a suggested use of chaperones as probes for the distribution of their target proteins. J. Histochem. Cytochem. 47 (1999) 1633-1640
40. Thorpe J.R., Morley S.J., and Rulten S.L. Utilising the peptidyl-prolyl cis-trans isomerase Pin1 as a probe of its phosphorylated target proteins: examples of binding to nuclear proteins in a human kidney cell line and to tau in Alzheimer's diseased brain. J. Histochem. Cytochem. 49 (2001) 97-108
41. Thorpe J.R., Mosaheb S., Hashemzadeh-Bonehi L., Cairns N.J., Kay K.E., Morley S.J., and Rulten S.L. Shortfalls in the peptidyl-prolyl cis-trans isomerase protein Pin1 in neurons are associated with frontotemporal dementias. Neurobiol. Dis. 17 (2004) 237-249
42. Zhou X.Z., Kops O., Werner A., Lu P.J., Shen M., Stoller G., Kullertz G., Stark M., Fischer G., and Lu K.P. Pin1-dependent prolyl isomerisation regulates dephosphorylation of Cdc25C and tau proteins. Mol. Cell 6 (2000) 873-883